UCLA is a leading center of treatment innovation and laboratory research in liver disease. The Asian Liver Program is at the forefront of clinical research, evaluating new, state-of-the-art medications for viral hepatitis B and C. Appropriate patients may be eligible to receive these investigational drugs as part of a clinical study.
UCLA researchers are currently involved in investigations in the areas of liver cancer, ischemia-reperfusion injury (damage caused by the return of blood flow to tissue in which the blood supply has been restricted) and transplant immunology. The goal of this basic-science research is to transfer knowledge gained in the laboratory into leading-edge therapies at patient bedsides.
Contact Us
(310) 825-1412 phone
(310) 267-0555 fax
[email protected]
